Jove
Visualize
Contact Us

Related Experiment Videos

Screening for hepatocellular carcinoma.

I Merican1

  • 1Department of Medicine, Hospital Kuala Lumpur.

The Medical Journal of Malaysia
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Early screening for hepatocellular carcinoma (HCC) in high-risk Asian males, particularly those with hepatitis B or C, improves detection and survival rates. Regular screening with ultrasound and AFP testing is recommended for at-risk individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic hepatitis C: the hope for a cure.

The Medical journal of Malaysia·2014
Same author

Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.

The Medical journal of Malaysia·2010
Same author

Clustering of hypertension, abnormal glucose tolerance, hypercholesterolaemia and obesity in Malaysian adult population.

The Medical journal of Malaysia·2009
Same author

Maternal deaths due to liver disease in Malaysia.

The Medical journal of Malaysia·2009
Same author

The Malaysian Liver Registry: a database of the common liver diseases.

The Medical journal of Malaysia·2009
Same author

Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B.

Gut·2007
Same journal

Diagnostic performance of computed tomography colonography following incomplete colonoscopy and its associated factors: A single-centre retrospective study.

The Medical journal of Malaysia·2026
Same journal

Gender representation across surgical specialties in Malaysia.

The Medical journal of Malaysia·2026
Same journal

Non-specific orbital inflammation: Clinical and histopathological insights from a 6-year single-centre Malaysian cohort.

The Medical journal of Malaysia·2026
Same journal

Prevalence of metabolic associated fatty liver disease (MAFLD) and its associated factors among type 2 diabetes mellitus (T2DM) in primary care settings in Kuantan, Pahang.

The Medical journal of Malaysia·2026
Same journal

Sixteen years of cochlear implant surgery in cochleovestibular malformation and cochlear nerve deficiency: Insights from northern Malaysia.

The Medical journal of Malaysia·2026
Same journal

Evaluation of vision-related quality of life and its associated factors in patients with diabetic vitreoretinal disease post trans pars plana vitrectomy using visual functioning questionnaire-25.

The Medical journal of Malaysia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Hepatology
  • Oncology
  • Public Health

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent cancer in Asian males, often diagnosed late with poor prognosis.
  • Cirrhosis associated with hepatitis B and C infections are common risk factors for HCC.
  • Late diagnosis in Malaysia leads to a high mortality rate within months of detection.

Purpose of the Study:

  • To evaluate the effectiveness of screening for early detection of hepatocellular carcinoma (HCC).
  • To identify high-risk populations for HCC screening.
  • To discuss the impact of screening on survival rates and compare regional outcomes.

Main Methods:

  • Review of current screening practices for HCC, including serum alpha-fetoprotein (AFP) and abdominal ultrasound.
  • Analysis of survival rates based on tumor size and treatment modality (surgical resection).

Related Experiment Videos

  • Discussion of cost-effectiveness and regional variations in HCC screening efficacy.

    • Main Results:

    • Early detection of small HCC tumors (<5 cm) through screening significantly improves survival rates, with 5-year survival reaching 68% after resection.
    • Smaller tumors (<2 cm) yield better outcomes.
    • Screening is most effective in high-incidence regions and for specific high-risk groups (e.g., >45 years with chronic hepatitis B/C, cirrhosis, or family history).

    Conclusions:

    • Screening for HCC is beneficial for early detection and improved survival, especially in high-risk populations.
    • Regular screening every 3-6 months is recommended for individuals with chronic hepatitis B/C, cirrhosis, or family history.
    • Primary prevention through hepatitis B vaccination and HCV screening holds significant long-term promise for HCC control.